-
EP1656367
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1656367
| EP1656367 - 4- (HETEROCYCLYL- FUSED PHENYL)- 3- (PHENYL OR PYRID -2- YL) PYRAZOLES AS INHIBITORS OF THE ALK-5- RECEPTOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.05.2009 Database last updated on 19.10.2024 | Most recent event Tooltip | 01.05.2009 | Application deemed to be withdrawn | published on 03.06.2009 [2009/23] | Applicant(s) | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza, P.O. Box 7929 Philadelphia Pennsylvania 19101 / US | [2006/20] | Inventor(s) | 01 /
DODIC, Nerina, Laboratoire GlaxoSmithKline Ctr. de Rech., ZA de Courtaboeuf, 25 Av. du Québec F-91951 Les Ulis / FR | 02 /
DONCHE, Frederic, Laboratoire GlaxoSmithKline Ctr. de Rech., ZA de Courtaboeuf, 25 Av. du Québec F-91951 Les Ulis / FR | 03 /
GELLIBERT, Francoise Jeanne, Lab. GlaxoSmithKline Ctr de Rech., ZA de Courtaboeuf, 25 Av. du Québec F-91951 Les Ulis / FR | [2006/20] | Representative(s) | Sardharwala, Fatema Elyasali GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG / GB | [N/P] |
| Former [2006/20] | Sardharwala, Fatema Elyasali GlaxoSmithKline Corporate Intellectual Property 980 Great West Road GB-Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 04739898.7 | 14.06.2004 | [2006/20] | WO2004EP06427 | Priority number, date | GB20030013915 | 16.06.2003 Original published format: GB 0313915 | [2006/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004111036 | Date: | 23.12.2004 | Language: | EN | [2004/52] | Type: | A1 Application with search report | No.: | EP1656367 | Date: | 17.05.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.12.2004 takes the place of the publication of the European patent application. | [2006/20] | Search report(s) | International search report - published on: | EP | 23.12.2004 | Classification | IPC: | C07D401/14, C07D413/14, A61K31/538, A61P13/12 | [2006/20] | CPC: |
C07D413/12 (EP);
A61P13/12 (EP);
C07D401/14 (EP);
C07D413/14 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/20] | Extension states | AL | Not yet paid | HR | 22.12.2005 | LT | 22.12.2005 | LV | 22.12.2005 | MK | Not yet paid | Title | German: | 4-(HETEROCYCLYLKONDENSIERTES PHENYL)-3-(PHENYL- ODER -PYRID-2-YL)PYRAZOLE ALS INHIBITOREN DES ALK-5-REZEPTORS | [2006/20] | English: | 4- (HETEROCYCLYL- FUSED PHENYL)- 3- (PHENYL OR PYRID -2- YL) PYRAZOLES AS INHIBITORS OF THE ALK-5- RECEPTOR | [2006/20] | French: | 4-(HETEROCYCLYLE-PHENYLE FUSIONNE)-3-PHENYLE OU PYRID-2-YLE)PYRAZOLES UTILISES COMME INHIBITEURS DU RECEPTEUR DE ALK-5 | [2006/20] | Entry into regional phase | 22.12.2005 | National basic fee paid | 22.12.2005 | Designation fee(s) paid | 22.12.2005 | Examination fee paid | Examination procedure | 22.12.2005 | Amendment by applicant (claims and/or description) | 22.12.2005 | Examination requested [2006/20] | 01.08.2008 | Despatch of a communication from the examining division (Time limit: M04) | 12.12.2008 | Application deemed to be withdrawn, date of legal effect [2009/23] | 19.01.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/23] | Fees paid | Renewal fee | 27.03.2006 | Renewal fee patent year 03 | 08.06.2007 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.2008 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [E]WO2004072033 (BIOGEN IDEC INC [US], et al) [E] 1-18 * Abstract; claims; examples e.g. example 2. *; | [PXD]WO2004026306 (PFIZER PROD INC [US], et al) [PXD] 1-18 * Abstract; claims; pages 39-41, test protocols; examples 2, 3, 7, 8, 17. *; | [PA]WO03055860 (RIBOTARGETS LTD [GB], et al) [PA] 1-18 * Abstract; claims; examples. *; | [X]JPH08183787 (EISAI CO LTD) [X] 1-7,13-15,17 * Examples. *; | [X]WO02072576 (PFIZER PROD INC [US], et al) [X] 1-18 * Abstract; claims; examples e.g. numbers 362, 371, etc. *; | [DY]WO02062794 (GLAXO GROUP LTD [GB], et al) [DY] 1-18 * Abstract; page 3, lines 15-19; claims. *; | [Y]WO0240476 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-18 * Abstract; page 1, paragraph 1; claims; examples. * | [PX] - DOMBROSKI, M. A. ET AL., "Benzimidazolone p38 inhibitors", BIOORG. MED. CHEM. LETT., (20040223), vol. 14, no. 4, pages 919 - 923, XP002297425 [PX] 1-18 * Compounds 16a-16c. * DOI: http://dx.doi.org/10.1016/j.bmcl.2003.12.023 |